Dan Lemaitre Biography and Net Worth

Director of Globus Medical

Daniel T. Lemaitre has served on our Board of Directors since April 2011 and is a member of our Compensation Committee and Audit Committee. Since September 2018, Mr. Lemaitre has served as Executive Chairman of BlueWind Medical, a neuromodulation company based in Israel. Mr. Lemaitre most recently served as the President and Chief Executive Officer of Direct Flow Medical.

Previously, Mr. Lemaitre served as Chief Executive Officer of White Pine Medical, a venture-backed medical device start-up company, from June 2009 until May 2015. Prior to White Pine Medical, Mr. Lemaitre served as the President and Chief Executive Officer of CoreValve, a privately-held company focused on percutaneous aortic valve replacement, from April 2008 until its acquisition by Medtronic, Inc., a publicly-traded medical device company, in April 2009. From 2005 until March 2008, Mr. Lemaitre was a Senior Vice President at Medtronic, where he led the company’s strategic planning and corporate development. Prior to joining Medtronic, Mr. Lemaitre spent 28 years as an investment analyst in the medical device field. This included 18 years with SG Cowen, where he was a managing director and led the healthcare research team, and six years with Merrill Lynch.

Mr. Lemaitre holds a B.A. in Economics from Bethany College and an M.B.A. from Bowling Green State University. Mr. Lemaitre also currently serves as the Chairman of the Board of Directors of Endologix, Inc.

What is Dan Lemaitre's net worth?: The estimated net worth of Dan Lemaitre is at least $892,404.00 as of May 15th, 2023. Mr. Lemaitre owns 10,800 shares of Globus Medical stock worth more than $892,404 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Lemaitre may own. Learn More about Dan Lemaitre's net worth.
How do I contact Dan Lemaitre?: The corporate mailing address for Mr. Lemaitre and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Dan Lemaitre's contact information.
Has Dan Lemaitre been buying or selling shares of Globus Medical?: Dan Lemaitre has not been actively trading shares of Globus Medical within the last three months. Most recently, Dan Lemaitre sold 63,300 shares of the business's stock in a transaction on Friday, May 10th. The shares were sold at an average price of $64.61, for a transaction totalling $4,089,813.00. Learn More on Dan Lemaitre's trading history.
Who are Globus Medical's active insiders?: Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.
Are insiders buying or selling shares of Globus Medical?: During the last year, insiders at the medical device company sold shares 9 times. They sold a total of 207,390 shares worth more than $14,740,737.10. The most recent insider tranaction occured on December, 2nd when SVP Kelly Huller sold 2,500 shares worth more than $217,500.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.
Information on this page was last updated on 12/2/2024.

Dan Lemaitre Insider Trading History at Globus Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/10/2024	Sell	63,300	$64.61	$4,089,813.00
5/15/2023	Sell	43,450	$56.98	$2,475,781.00	10,800

Dan Lemaitre Buying and Selling Activity at Globus Medical

Globus Medical Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Today's Range

Now: $82.63

$81.27

$83.27

50 Day Range

MA: $80.02

$71.15

$85.61

2 Week Range

Now: $82.63

$49.33

$87.22

Volume

2,828,484 shs

Average Volume

1,002,211 shs

Market Capitalization

$11.25 billion

P/E Ratio

123.33

Dividend Yield

N/A

Beta

1.19

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.